Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-29

FDA Approved: PENTASA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for PENTASA (mesalamine) from Takeda Pharmaceuticals America, Inc., representing an FDA-approved change to the produ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PENTASA (MESALAMINE)

Snippet

SUPPL AP for PENTASA (MESALAMINE)